The patent EP4560709A1 was granted to Nivarox FAR on May 28, 2025 following the initial filing on Nov 23, 2023 under the application number EP23211818A . The current legal status of the patent is Published.
The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Date
Description
Get instant alerts for new documents